Exploiting IL-17-producing CD4(+) and CD8(+) T cells to improve cancer immunotherapy in the clinic

Cancer immunotherapy is one the most effective approaches for treating patients with tumors, as it bolsters the generation and persistence of memory T cells. In preclinical work, it has been reported that adoptively transferred CD4(+) and CD8(+) lymphocytes that secrete IL-17A (i.e., Th17 and Tc17 c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Immunol Immunother
Main Authors: Majchrzak, Kinga, Nelson, Michelle H., Bailey, Stefanie R., Bowers, Jacob S., Yu, Xue-Zhong, Rubinstein, Mark P., Himes, Richard A., Paulos, Chrystal M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2016
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5115162/
https://ncbi.nlm.nih.gov/pubmed/26825102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-016-1797-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados